Enfusion, Inc.·4

Sep 21, 4:15 PM ET

Groman Dan 4

4 · Enfusion, Inc. · Filed Sep 21, 2023

Insider Transaction Report

Form 4
Period: 2023-09-19
Groman Dan
Chief Technology Officer
Transactions
  • Sale

    Class A Common Stock

    2023-09-19$9.07/sh5,000$45,350143,828 total
Footnotes (2)
  • [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 15, 2023.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.00 to $9.12. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.

Documents

1 file
  • 4
    tm2326639-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT